North America Aluminum Curtain Wall Market To Reach USD 18.1 Billion By 2032 Report By DataHorizzon Research
March 12, 2024 09:30 ET
|
DataHorizzon Research
Fort Collins, Colorado, March 12, 2024 (GLOBE NEWSWIRE) -- The North America Auminum Curtain Wall Market size was valued at USD 7.6 Billion in 2023 and is expected to reach a market size of USD 18.1...
Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
March 07, 2024 18:49 ET
|
Apogee Therapeutics, LLC
SAN FRANCISCO and WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company seeking to develop differentiated biologics for...
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
March 05, 2024 16:23 ET
|
Apogee Therapeutics, LLC
SAN FRANCISCO and WALTHAM, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company seeking to develop differentiated biologics for...
Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
March 05, 2024 06:10 ET
|
Apogee Therapeutics, LLC
Positive interim results from APG777 Phase 1 healthy volunteer clinical trial exceeded objectives with approximately 75-day half-life which supports the potential for higher exposures leading to...
Apogee Announces Positive Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases, Exceeding its Trial Objectives Ahead of Schedule with Half-Life of Approximately 75 Days
March 05, 2024 06:00 ET
|
Apogee Therapeutics, LLC
Pharmacokinetic data support potential best-in-class profile with potential for improved clinical responses from greater exposures in induction than currently available biologic therapies and...
Apogee to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases on March 5, 2024
March 04, 2024 16:01 ET
|
Apogee Therapeutics, LLC
SAN FRANCISCO and WALTHAM, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...
Quantum Sensor Market to Reach $1.11 Billion, Globally, by 2032 at 14.07% CAGR: Allied Market Research
February 23, 2024 11:41 ET
|
Allied Analytics LLP
Wilmington, Delaware, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Quantum Sensors Market by Product Type (Atomic Clocks, Magnetic Sensors, PAR Quantum...
Global Audio Interface Market Size To Worth USD 298.2 Million By 2033 | CAGR Of 5.76%
February 12, 2024 03:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Feb. 12, 2024 (GLOBE NEWSWIRE) -- The Global Audio Interface Market Size is to Grow from USD 170.4 Million in 2023 to USD 298.2 Million by 2033, at a Compound Annual Growth...
EnergyX is Acquired by Apogee Interactive to Enhance Platform That Improves Energy Savings Programs for Utilities
February 07, 2024 08:05 ET
|
Apogee Interactive, Inc.
Apogee Interactive announced the acquisition of EnergyX Solutions, an Ontario-based creator of artificial-intelligence-powered software for utilities.
Flow Cytometry Market To Reach USD 9.6 Billion By 2032 Report By DataHorizzon Research
February 06, 2024 06:30 ET
|
DataHorizzon Research
Fort Collins, Colorado, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The Flow Cytometry Market size was valued at USD 4.5 Billion in 2022 and is anticipated to reach USD 9.6 Billion by 2032 at a CAGR of 7.9%. ...